dc.creator | Casanova, Ciro | es |
dc.creator | Marin, Jose M | es |
dc.creator | Martínez-González, Cristina | es |
dc.creator | Lucas-Ramos, Pilar de | es |
dc.creator | Mir-Viladrich, Isabel | es |
dc.creator | Cosio, Borja | es |
dc.creator | Alfageme Michavila, Inmaculada | es |
dc.creator | López-Campos Bodineau, José Luis | es |
dc.creator | Torres, Juan de | es |
dc.date.accessioned | 2021-08-26T11:10:41Z | |
dc.date.available | 2021-08-26T11:10:41Z | |
dc.date.issued | 2014-01-13 | |
dc.identifier.citation | Casanova, C., Marin, J.M., Martínez-González, C., Lucas-Ramos, P.d., Mir-Viladrich, I., Cosio, B.,...,de Torres, J. (2014). New GOLD classification: longitudinal data on group assignment. Respiratory Research, 15 (1), art.n.3. | |
dc.identifier.issn | 1465-9921 (impreso) | es |
dc.identifier.issn | 1465-993X (electrónico) | es |
dc.identifier.uri | https://hdl.handle.net/11441/125192 | |
dc.description.abstract | Rationale: Little is known about the longitudinal changes associated with using the 2013 update of the
multidimensional GOLD strategy for chronic obstructive pulmonary disease (COPD).
Objective: To determine the COPD patient distribution of the new GOLD proposal and evaluate how this
classification changes over one year compared with the previous GOLD staging based on spirometry only.
Methods: We analyzed data from the CHAIN study, a multicenter observational Spanish cohort of COPD patients
who are monitored annually. Categories were defined according to the proposed GOLD: FEV1%, mMRC dyspnea,
COPD Assessment Test (CAT), Clinical COPD Questionnaire (CCQ), and exacerbations-hospitalizations. One-year
follow-up information was available for all variables except CCQ data.
Results: At baseline, 828 stable COPD patients were evaluated. On the basis of mMRC dyspnea versus CAT, the
patients were distributed as follows: 38.2% vs. 27.2% in group A, 17.6% vs. 28.3% in group B, 15.8% vs. 12.9% in
group C, and 28.4% vs. 31.6% in group D. Information was available for 526 patients at one year: 64.2% of patients
remained in the same group but groups C and D show different degrees of variability. The annual progression by
group was mainly associated with one-year changes in CAT scores (RR, 1.138; 95%CI: 1.074-1.206) and BODE index
values (RR, 2.012; 95%CI: 1.487-2.722).
Conclusions: In the new GOLD grading classification, the type of tool used to determine the level of symptoms
can substantially alter the group assignment. A change in category after one year was associated with longitudinal
changes in the CAT and BODE index. | es |
dc.format | application/pdf | es |
dc.format.extent | 9 p. | es |
dc.language.iso | eng | es |
dc.publisher | BMC | es |
dc.relation.ispartof | Respiratory Research, 15 (1), art.n.3. | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | COPD | es |
dc.subject | GOLD | es |
dc.subject | Longitudinal | es |
dc.title | New GOLD classification: longitudinal data on group assignment | es |
dc.type | info:eu-repo/semantics/article | es |
dcterms.identifier | https://ror.org/03yxnpp24 | |
dc.type.version | info:eu-repo/semantics/publishedVersion | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.contributor.affiliation | Universidad de Sevilla. Departamento de Medicina | es |
dc.relation.publisherversion | https://respiratory-research.biomedcentral.com/articles/10.1186/1465-9921-15-3 | es |
dc.identifier.doi | 10.1186/1465-9921-15-3 | es |
dc.journaltitle | Respiratory Research | es |
dc.publication.volumen | 15 | es |
dc.publication.issue | 1 | es |
dc.publication.initialPage | art.n.3 | es |